News | Clinical Decision Support | October 27, 2016

NCCN Imaging AUC provide a single access point for all oncology imaging recommendations within the NCCN Guidelines; criteria now available for 20 cancer types

October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use criteria (AUC) and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types.

NCCN is  a Centers for Medicare & Medicaid Services (CMS)-approved provider-led entity for imaging appropriate use criteria (AUC). Launched in June 2016, NCCN Imaging AUC currently are available for 20 cancer types.

The new NCCN Imaging AUC are available for:

  • Esophageal and Esophagogastric Junction Cancers;
  • Gastric Cancer;
  • Malignant Pleural Mesothelioma;
  • Melanoma;
  • Ovarian Cancer;
  • Penile Cancer;
  • Small Cell Lung Cancer; and
  • Thymomas and Thymic Carcinomas.

NCCN Imaging AUC are an easy-to-use, single source for AUC pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up and surveillance as outlined within the library of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). NCCN Imaging AUC include all imaging procedures recommended in the NCCN Guidelines, including radiographs, computed tomography (CT) scans, magnetic resonance imaging (MRI), functional nuclear medicine imaging (positron emission tomography [PET], single photon emission computed tomography [SPECT]) and ultrasound.

NCCN Imaging AUC are available through a web-based user interface that provides a searchable and user-customized display of approved NCCN Imaging AUC. The complete library will be available beginning quarter 2 2017.

For more information: www.nccn.org


Related Content

News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image ...

Time February 28, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 28, 2024 — Royal Philips, a global leader in health technology, today announced a significant milestone as it ...

Time February 28, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — As artificial intelligence (AI) is increasingly used in radiology, researchers caution that it’s ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Time February 21, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 16, 2024 — Fujifilm Healthcare Europe will be presenting the Echelon Synergy – a revolutionary MRI scanner for ...

Time February 16, 2024
arrow
News | SPECT Imaging

February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling ...

Time February 15, 2024
arrow
News | Ultrasound Imaging

February 15, 2024 — Clarius Mobile Health, a global leader in wireless ultrasound solutions, announces T-Mode AI, a ...

Time February 15, 2024
arrow
Subscribe Now